In patients with HIV infection on rifampicin TB therapy, twice-daily bictegravir/emtricitabine/tenofovir alafenamide results ...

Large language models could transform digestive disorder management, but further RCTs are essential to validate their ...

Adding a daily fish oil supplement to psychotherapy showed no significant benefit over placebo for kids and teens with ...

HUTCHMED has commenced the Phase III stage of its ongoing Phase II/III clinical trial assessing the combination of ...

Social robots are efficacious and effective for children with autism, according to a study published online Dec. 24 in ...

Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...

A large U.S. randomized trial published in the New England Journal of Medicine found that etomidate, compared with ketamine, ...

Ascletis Pharma has received investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to begin ...

The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...

A new drug application (NDA) has been submitted to the FDA seeking approval of rusfertide, an investigational hepcidin ...

Early intensive BP control significantly reduces cardiovascular risk in older patients compared with delayed initiation of treatment.

The BigpAK-2 randomized prospective multicenter trial tested implementation of a bundle of measures to prevent acute kidney injury in high-risk patients undergoing major surgery. Trial results support ...